This brand name is authorized in Ireland, Malta, New Zealand, United Kingdom
The drug DEPIXOL contains one active pharmaceutical ingredient (API):
|
1
Flupentixol
UNII 3B2FE28C1W - FLUPENTIXOL DECANOATE
|
|
|
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| DEPIXOL Film-coated tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| DEPIXOL Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N05AF01 | Flupentixol | N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AF Thioxanthene derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 31014, 31024, 31033, 31042, 36800 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 61816, 84069 |
| Country: MT | Medicines Authority | Identifier(s): MA1323/00201, MA1323/00202 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 2585, 2588 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
